A new therapy that combines imaging and targeted radiation is being explored for the treatment of aggressive bone cancer. This approach, known as theranostics, is also being investigated for its potential to treat other types of cancer, including prostate and pancreatic cancer. The therapy is being studied in clinical trials, with some institutions reporting early results and others planning to discuss its emerging role in cancer treatment.